Does the Q4 earnings transcript contain new financial guidance?

No. The transcript confirms previously disclosed targets of 15-20% revenue growth and 18-20% EBITDA margins.

Are there updates on capacity expansion plans?

The transcript reiterates the same expansion timelines that were communicated in earlier filings and investor presentations.

Should investors expect any material surprises from this filing?

No. The filing is a routine record of known data and contains no new material developments.

Earnings · Household & Personal Products · Small cap

Carysil's Q4 transcript offers no surprises

The latest earnings call transcript confirms existing guidance and expansion plans, adding no new material information.

— 1 earlier story on Carysil Ltd. →

CARYSIL 27 May 2026 · 2:48 PM IST Verify on BSE · NSE

Mkt cap₹3,118 cr

P/E31.76×

ROE12.11%

Debt / eq.0.50

Div yld0.27%

15-20% Revenue growth guidance reaffirmed for FY2026.

What's new

The Q4 FY2026 earnings call transcript contains no new material developments.
Management reaffirmed revenue growth targets of 15-20%.
EBITDA margin guidance remains set at 18-20%.

Why this matters

The transcript is a routine record of previously disclosed financial results and strategic plans. Investors looking for incremental updates on capacity expansion or margin shifts will find nothing new here.

What we're watching

Actual execution of capacity expansion timelines.
Whether margins hold within the 18-20% target range.
Any deviation from the 15-20% revenue growth path.

The full read

Carysil's Q4 FY2026 earnings call transcript provides a detailed review of the company's performance, but it breaks no new ground. Management used the call to reiterate existing guidance, specifically targeting 15-20% revenue growth and 18-20% EBITDA margins. The transcript also confirms that capacity expansion timelines remain unchanged from previous disclosures.

No surprises here.

This filing is a standard record of the quarter rather than a source of fresh insight, confirming that the company is sticking to its previously communicated strategy while maintaining a steady operational pace despite the lack of new information for the market to digest.

Questions answered

Does the Q4 earnings transcript contain new financial guidance?: No. The transcript confirms previously disclosed targets of 15-20% revenue growth and 18-20% EBITDA margins.
Are there updates on capacity expansion plans?: The transcript reiterates the same expansion timelines that were communicated in earlier filings and investor presentations.
Should investors expect any material surprises from this filing?: No. The filing is a routine record of known data and contains no new material developments.

Mentioned: Carysil Ltd.

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on CARYSIL →

27 May 2026 · 2:48 PM IST Carysil's Q4 transcript offers no surprises
6d ago Carysil's capacity expansion timelines pushed back by 9-12 months